These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 37542226)
1. Deprescribing research in nursing home residents using routinely collected healthcare data: a conceptual framework. Thorpe C; Niznik J; Li A BMC Geriatr; 2023 Aug; 23(1):469. PubMed ID: 37542226 [TBL] [Abstract][Full Text] [Related]
2. Health Outcomes of Deprescribing Interventions Among Older Residents in Nursing Homes: A Systematic Review and Meta-analysis. Kua CH; Mak VSL; Huey Lee SW J Am Med Dir Assoc; 2019 Mar; 20(3):362-372.e11. PubMed ID: 30581126 [TBL] [Abstract][Full Text] [Related]
3. Prescriber Perspectives and Experiences with Deprescribing Versus Continuing Bisphosphonates in Older Nursing Home Residents with Dementia. Niznik J; Colón-Emeric C; Thorpe CT; Kelley CJ; Gilliam M; Lund JL; Hanson LC J Gen Intern Med; 2023 Nov; 38(15):3372-3380. PubMed ID: 37369891 [TBL] [Abstract][Full Text] [Related]
4. Deprescribing in Nursing Home Residents on Polypharmacy: Incidence and Associated Factors. Onder G; Vetrano DL; Villani ER; Carfì A; Lo Monaco MR; Cipriani MC; Manes Gravina E; Denkinger M; Pagano F; van der Roest HG; Bernabei R J Am Med Dir Assoc; 2019 Sep; 20(9):1116-1120. PubMed ID: 30853425 [TBL] [Abstract][Full Text] [Related]
5. Effects of an interprofessional Quality Circle-Deprescribing Module (QC-DeMo) in Swiss nursing homes: a randomised controlled trial. Cateau D; Ballabeni P; Niquille A BMC Geriatr; 2021 May; 21(1):289. PubMed ID: 33933030 [TBL] [Abstract][Full Text] [Related]
6. Impact of a pharmacist-administered deprescribing intervention on nursing home residents: a randomized controlled trial. Balsom C; Pittman N; King R; Kelly D Int J Clin Pharm; 2020 Aug; 42(4):1153-1167. PubMed ID: 32494991 [TBL] [Abstract][Full Text] [Related]
7. Benzodiazepine Use and Deprescribing in Belgian Nursing Homes: Results from the COME-ON Study. Evrard P; Henrard S; Foulon V; Spinewine A J Am Geriatr Soc; 2020 Dec; 68(12):2768-2777. PubMed ID: 32786002 [TBL] [Abstract][Full Text] [Related]
8. Pharmacist-Led Deprescribing Using STOPPFrail for Frail Older Adults in Nursing Homes. Hurley E; Dalton K; Byrne S; Foley T; Walsh E J Am Med Dir Assoc; 2024 Sep; 25(9):105122. PubMed ID: 38950585 [TBL] [Abstract][Full Text] [Related]
9. Nursing home team-care deprescribing study: a stepped-wedge randomised controlled trial protocol. Kua CH; Yeo CYY; Char CWT; Tan CWY; Tan PC; Mak VS; Lee SWH; Leong IY BMJ Open; 2017 May; 7(5):e015293. PubMed ID: 28490560 [TBL] [Abstract][Full Text] [Related]
10. Spread and scale of an electronic deprescribing software to improve health outcomes of older adults living in nursing homes: study protocol for a stepped wedge cluster randomized trial. Nadeau ME; Henry JL; Lee TC; Bortolussi-Courval É; Goodine C; McDonald EG Trials; 2021 Nov; 22(1):763. PubMed ID: 34727956 [TBL] [Abstract][Full Text] [Related]
11. Clinical impact of medication review and deprescribing in older inpatients: A systematic review and meta-analysis. Carollo M; Crisafulli S; Vitturi G; Besco M; Hinek D; Sartorio A; Tanara V; Spadacini G; Selleri M; Zanconato V; Fava C; Minuz P; Zamboni M; Trifirò G J Am Geriatr Soc; 2024 Oct; 72(10):3219-3238. PubMed ID: 38822740 [TBL] [Abstract][Full Text] [Related]
12. Implementation of interprofessional quality circles on deprescribing in Swiss nursing homes: an observational study. Mena S; Moullin JC; Schneider M; Niquille A BMC Geriatr; 2023 Oct; 23(1):620. PubMed ID: 37789286 [TBL] [Abstract][Full Text] [Related]
13. Polypharmacy and potentially inappropriate prescribing of benzodiazepines in older nursing home residents. Kummer I; Reissigová J; Lukačišinová A; Ortner Hadžiabdić M; Stuhec M; Liperoti R; Finne-Soveri H; Onder G; van Hout H; Fialová D Ann Med; 2024 Dec; 56(1):2357232. PubMed ID: 38833339 [TBL] [Abstract][Full Text] [Related]
14. Clinician and Family Caregiver Perspectives on Deprescribing Chronic Disease Medications in Older Nursing Home Residents Near the End of Life. Schleiden LJ; Klima G; Rodriguez KL; Ersek M; Robinson JE; Hickson RP; Smith D; Cashy J; Sileanu FE; Thorpe CT Drugs Aging; 2024 Apr; 41(4):367-377. PubMed ID: 38575748 [TBL] [Abstract][Full Text] [Related]
15. Effects of an interprofessional deprescribing intervention in Swiss nursing homes: the Individual Deprescribing Intervention (IDeI) randomised controlled trial. Cateau D; Ballabeni P; Niquille A BMC Geriatr; 2021 Nov; 21(1):655. PubMed ID: 34798826 [TBL] [Abstract][Full Text] [Related]
16. The value of deprescribing in older adults with dementia: a narrative review. Sawan MJ; Moga DC; Ma MJ; Ng JC; Johnell K; Gnjidic D Expert Rev Clin Pharmacol; 2021 Nov; 14(11):1367-1382. PubMed ID: 34311630 [No Abstract] [Full Text] [Related]
17. Deprescribing in nursing homes: Protocol for nested, randomised controlled hybrid trials of deprescribing interventions. Cateau D; Ballabeni P; Mena S; Bugnon O; Niquille A Res Social Adm Pharm; 2021 Apr; 17(4):786-794. PubMed ID: 32622774 [TBL] [Abstract][Full Text] [Related]
18. Patterns of oral bisphosphonate deprescribing in older nursing home residents with dementia. Niznik JD; Aspinall SL; Hanson LC; Gilliam MA; Li X; Kelley CJ; Thorpe CT Osteoporos Int; 2022 Feb; 33(2):379-390. PubMed ID: 34480586 [TBL] [Abstract][Full Text] [Related]
19. Balancing medication use in nursing home residents with life-limiting disease. Paque K; Elseviers M; Vander Stichele R; Pardon K; Vinkeroye C; Deliens L; Christiaens T; Dilles T Eur J Clin Pharmacol; 2019 Jul; 75(7):969-977. PubMed ID: 30834473 [TBL] [Abstract][Full Text] [Related]
20. Deprescribing Medications Among Older Adults From End of Hospitalization Through Postacute Care: A Shed-MEDS Randomized Clinical Trial. Vasilevskis EE; Shah AS; Hollingsworth EK; Shotwell MS; Kripalani S; Mixon AS; Simmons SF JAMA Intern Med; 2023 Mar; 183(3):223-231. PubMed ID: 36745422 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]